[HTML][HTML] p63 and p53: Collaborative partners or dueling rivals?

DL Woodstock, MA Sammons… - Frontiers in Cell and …, 2021 - frontiersin.org
The tumor suppressor p53 and its oncogenic sibling p63 (ΔNp63) direct opposing fates in
tumor development. These paralog proteins are transcription factors that elicit their tumor …

[HTML][HTML] Mutant p63 affects epidermal cell identity through rewiring the enhancer landscape

J Qu, SEJ Tanis, JPH Smits, EN Kouwenhoven, M Oti… - Cell reports, 2018 - cell.com
Transcription factor p63 is a key regulator of epidermal keratinocyte proliferation and
differentiation. Mutations in the p63 DNA-binding domain are associated with ectrodactyly …

ΔNp63-mediated regulation of hyaluronic acid metabolism and signaling supports HNSCC tumorigenesis

M Compagnone, V Gatti, D Presutti… - Proceedings of the …, 2017 - National Acad Sciences
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer
worldwide, and several molecular pathways that underlie the molecular tumorigenesis of …

ΔNp63 targets cytoglobin to inhibit oxidative stress-induced apoptosis in keratinocytes and lung cancer

A Latina, G Viticchiè, AM Lena, MC Piro… - Oncogene, 2016 - nature.com
During physiological aerobic metabolism, the epidermis undergoes significant oxidative
stress as a result of the production of reactive oxygen species (ROS). To maintain a …

Mcl-1 and FBW7 control a dominant survival pathway underlying HDAC and Bcl-2 inhibitor synergy in squamous cell carcinoma

L He, K Torres-Lockhart, N Forster, S Ramakrishnan… - Cancer discovery, 2013 - AACR
Effective targeted therapeutics for squamous cell carcinoma (SCC) are lacking. Here, we
uncover Mcl-1 as a dominant and tissue-specific survival factor in SCC, providing a roadmap …

[HTML][HTML] Intrinsic aggregation propensity of the p63 and p73 TI domains correlates with p53R175H interaction and suggests further significance of aggregation events …

S Kehrloesser, C Osterburg, M Tuppi… - Cell Death & …, 2016 - nature.com
The high percentage of p53 missense mutations found in cancer has been attributed to
mutant acquired oncogenic gain of functions. Different aspects of these tumour-promoting …

Single and dual target inhibitors based on Bcl-2: Promising anti-tumor agents for cancer therapy

T Liu, Z Wu, Y He, Y Xiao, C Xia - European Journal of Medicinal Chemistry, 2020 - Elsevier
Abstract B-cell lymphoma-2 (Bcl-2) proteins family is an essential checkpoint in apoptosis.
Extensive evidences suggested that overexpression of anti-apoptotic Bcl-2 proteins can be …

[HTML][HTML] ΔNp63α suppresses TGFB2 expression and RHOA activity to drive cell proliferation in squamous cell carcinomas

CG Abraham, MP Ludwig, Z Andrysik, A Pandey… - Cell reports, 2018 - cell.com
The transcriptional repressor ΔNp63α is a potent oncogene widely overexpressed in
squamous cell carcinomas (SCCs) of diverse tissue origins, where it promotes malignant …

Targeting schistosome histone modifying enzymes for drug development

RJ Pierce, F Dubois-Abdesselem… - Current …, 2012 - ingentaconnect.com
The histone modifying enzymes (HME) represent particularly promising targets for the
development of alternatives to praziquantel, the only currently available drug to combat …

Divergent roles of HDAC1 and HDAC2 in the regulation of epidermal development and tumorigenesis

M Winter, MA Moser, D Meunier, C Fischer… - The EMBO …, 2013 - embopress.org
The histone deacetylases HDAC1 and HDAC2 remove acetyl moieties from lysine residues
of histones and other proteins and are important regulators of gene expression. By deleting …